Independent study shows favorable long term prognosis for CP-GEP Low Risk melanoma patients

ROTTERDAM, Netherlands and SAN DIEGO, March 17, 2023 /PRNewswire/ — SkylineDx, an innovative diagnostics company, focused on research & development of molecular diagnostics for oncology and inflammatory diseases, today announced the publication of an independent study showing that gene…